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ABSTRACT
The SET- and MYND-domain containing (Smyd)
proteins constitute a special subfamily of the
SET-containing lysine methyltransferases. Here we
present the structure of full-length human Smyd3 in
complex with S-adenosyl-L-homocysteine at 2.8A ˚
resolution. Smyd3 affords the first example that
other region(s) besides the SET domain and its
flanking regions participate in the formation of the
active site. Structural analysis shows that the previ-
ously uncharacterized C-terminal domain of Smyd3
contains a tetratrico-peptide repeat (TPR) domain
which together with the SET and post-SET
domains forms a deep, narrow substrate binding
pocket. Our data demonstrate the important roles
of both TPR and post-SET domains in the histone
lysine methyltransferase (HKMT) activity of Smyd3,
and show that the hydroxyl group of Tyr239 is
critical for the enzymatic activity. The characteristic
MYND domain is located nearby to the substrate
binding pocket and exhibits a largely positively
charged surface. Further biochemical assays show
that DNA binding of Smyd3 can stimulate its HKMT
activity and the process may be mediated via the
MYND domain through direct DNA binding.
INTRODUCTION
It has been well established that covalent modiﬁcations of
histones are involved in the regulation of chromatin struc-
ture and function and hence play critical roles during
development and disease pathogenesis (1). Histone
methylation, one of the major forms of histone modiﬁca-
tion, has been shown to exert important functions in
various biological processes such as heterochromatin
formation, X-chromosome inactivation and transcription-
al regulation (2). Methylation of histones can occur at
different lysine or arginine residues and is correspondingly
catalyzed by various methyltransferases. Since about
a decade ago when it was discovered that the SET
domain-containing proteins are able to selectively methy-
late lysine residues of histones (3,4), the SET family
histone lysine methyltransferases (HKMTs) have been
found to be responsible for methylation of all (H3K4,
H3K9, H3K27, H3K36 and H4K20) but one lysine
residue (H3K79) of histones (5).
In contrast to the vast majority of the SET-containing
lysine methyltransferase, ﬁve proteins share a special
characteristic with the SET domain being split by
a myeloid-Nervy-DEAF-1 (MYND) insertion, and thus
cluster to a subfamily named SET- and MYND-domain
containing proteins (Smyd) (6,7). In the Smyd subfamily,
three proteins have been proven to possess methyl-
transferase activities: Smyd1 is able to speciﬁcally methy-
late histone H3-Lys4 (H3K4) (8); Smyd2 harbors a
methyltransferase activity towards histone H3-Lys36
(H3K36) (7,9), p53-Lys370 (10), and probably H3K4 as
well (9); and Smyd3 speciﬁcally catalyzes di- and tri-
methylation of H3K4 (6) and methylation of Lys831
of vascular endothelial growth factor receptor 1
(VEGFR1) (11).
Consistent with the HKMT function of Smyd3 for
methylation of H3K4 which is a hallmark of active gene
transcription (12–14), Smyd3 has been demonstrated to
bind with RNA helicase HELZ and hence is associated
with RNA polymerase II for transcription elongation
(6). The other substrate of Smyd3, VEGFR1, plays an
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shown to be involved in inﬂammatory responses, tumor
growth and atherosclerosis (15). Given the functional roles
of Smyd3 in gene transcription and the VEGFR1
signaling pathway, it is not surprising that dysregulation
of Smyd3 is involved in disease pathogenesis. Smyd3
was originally identiﬁed as a gene overexpressed in
hepatocellular carcinoma (HCC) and colorectal carcin-
oma (CRC) cells (6). Upregulation of Smyd3 promoted
the growth of HCC and CRC cells (6), and the presence
of three tandem repeats of an E2F-1-binding element in
the Smyd3 promoter region is a risk factor for HCC, CRC
and breast cancer (16).
Despite the important functional roles of Smyd3 and its
association with cancers, the knowledge about the molecu-
lar mechanism of its methyltransferase activity and the
regulation of the enzymatic activity is quite limited.
It has been suggested that the MYND domain might
bind speciﬁc DNA elements, and a chaperon, namely
heatshock protein 90 a (Hsp90a) has been demonstrated
to interact with Smyd3 and enhance its HKMT activity in
a dose-dependent manner (6). However, the potential
function and structural basis of the DNA binding by the
MYND domain of Smyd3, and the mechanism underlying
the regulation of the HKMT activity of Smyd3 by Hsp90a
remain unclear. In addition, more fundamental questions
about Smyd3 and the other Smyd proteins are in queue to
be answered. For example, it has been well known that the
‘pre-SET’ and ‘post-SET’ domains are necessary for the
activity of SUV39H1 (3); however, for the Smyd subfam-
ily members, there is no ‘pre-SET’ domain, and the exact
function of the ‘post-SET’ domain has not been
investigated yet. In addition, all Smyd proteins except
Smyd5 have a large C-terminal region, but the structure
and function of the region are still unknown.
We carried out structural and functional studies
of human Smyd3, and present here the crystal structure
of Smyd3 in complex with the cofactor product,
S-adenosyl-L-homocysteine (AdoHcy) at 2.8A ˚ resolution.
Comparison of the Smyd3–AdoHcy complex with the
reported structures of other SET enzymes (17–29)
reveals unique structural characteristics of Smyd3. Based
on the structural information, we further performed
mutagenesis analyses and biochemical assays. Together,
our results reveal the unique features of Smyd3
compared with the other SET methyltransferases, and
provide insights into the structural basis and regulatory
mechanism of the HKMT activity of Smyd3.
MATERIALS AND METHODS
Protein expression and puriﬁcation
The full-length human Smyd3 gene was ampliﬁed with
PCR from HEK293 cDNA and was subcloned into the
pET-28a and pET-28b vectors (Novagen) with a His6 tag
at the N-terminus or the C-terminus. The constructed
plasmids were transformed into Escherichia coli BL21
(DE3) Codon Plus strain. The bacterial cells were grown
in LB medium at 37 Ct oO D 600 of 0.6, and induced with
0.2mM isopropyl-b-D-thiogalactopyranoside at 16 C for
24h. The cells were collected by centrifugation at 6000g,
suspended in a lysis buffer [50 mM Tris–HCl (pH 8.0),
300mM NaCl, 5mM b-mercaptoethanol, 10% glycerol
and 1mM phenylmethylsulfonyl ﬂuoride], and lysed on
ice by sonication. The cell lysate was precipitated by cen-
trifugation at 18000g for 30min, and the supernatant was
used for protein puriﬁcation.
The human Smyd3 protein was puriﬁed by afﬁnity chro-
matography using a Ni
2+-NTA column (Qiagen)
equilibrated with a binding buffer [20 mM Tris–HCl
(pH 8.0), 300mM NaCl and 5mM b-mercaptoethanol].
The column was washed with the binding buffer supple-
mented with 30mM imidazole, and then the target protein
was eluted with the binding buffer supplemented with
200mM imidazole. The protein sample was further
puriﬁed by gel ﬁltration using Superdex 200 16/60
column (Amersham Biosciences). Finally, half of the
protein was stored in storage buffer A containing 20mM
Tris–HCl (pH 8.0), 100mM NaCl and 1mM DTT, while
the rest in buffer B containing 20mM Tris–HCl (pH 8.0),
50mM Li2SO4 and 1mM DTT.
The Smyd3 mutants were generated using the
QuikChange site-directed mutagenesis kit (Stratagene)
and veriﬁed by sequencing. Expression and puriﬁcation
of the mutant proteins were performed following the
same procedure as for the wild-type protein.
Crystallization, diffraction data collection and structure
determination
The puriﬁed C-terminally tagged Smyd3 protein was
concentrated to 5–10mg/ml in storage buffers (A and B)
and then incubated with 600mM AdoHcy. Crystallization
was performed using the hanging drop vapor diffusion
method. Crystals belonging to space group P21 (form I)
were obtained at 4 C with an equal volume of the protein
in storage buffer A and the reservoir solution containing
80mM sodium cacodylate (pH 6.5), 160mM calcium
acetate, 14.4% polyethylene glycol 8000 and 20%
glycerol. Crystals belonging to space group P212121
(form II) were obtained with the protein in storage
buffer B and the reservoir solution containing 2.8M
sodium acetate (pH 7.0).
The puriﬁed N-terminally tagged Smyd3 protein was
concentrated to 7.5–15mg/ml in storage buffer A, and
then incubated with 600mM AdoHcy. Crystals belonging
to space group P61 (form III) were obtained using the
sitting drop vapor diffusion method with the reservoir
solution containing 0.1M bicine (pH 9.0), 0.1M NaCl
and 20% polyethylene glycol monomethyl ether 550.
The diffraction data were collected from ﬂash-cooled
crystals at 100 K at beamline 17U of Shanghai
Synchrotron Radiation Facility, China. The diffraction
data were processed, integrated and scaled together with
HKL2000 (30). The statistics of the diffraction data are
summarized in Table 1. The structure of Smyd3 in
complex with AdoHcy was solved by the molecular
replacement method using CNS (31) with the structure
of Smyd3 in complex with S-adenosylmethionine
(AdoMet) as the search model (PDB code 3MEK). The
model building was performed using Coot (32), and the
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REFMAC5 (33). The stereochemical geometry of the
structures was analyzed using Procheck (34). The ﬁgures
were generated using Pymol (http://www.pymol.org). The
statistics of the structure reﬁnement and the quality of the
ﬁnal structure models are also summarized in Table 1. The
structural model derived from form I crystals has the
highest resolution and best quality. For this crystal
form, there are two molecules in an asymmetric unit,
and the NCS restraint was applied during the initial re-
ﬁnement but released in the later stage of reﬁnement. The
two molecules assume almost identical overall structures
[superposition of all Ca atoms yields a root-mean-square
deviation (RMSD) of 0.27A ˚ ], and the molecule with more
detectable residues and better electron density was chosen
for structural analyses and discussion in this article.
Gel shift assay
Different amounts of the wild-type and mutant Smyd3
proteins were incubated with 1mg 6bp DNA (50-CCCTC
C-30) in a buffer containing 50mM Tris–HCl (pH 7.4),
100mM NaCl and 1mM DTT. After incubation at 30 C
for 2h, the samples were loaded to a 2% agarose gel and
visualized under UV with Gel Green staining.
In vitro HKMT activity assay
For the HKMT activity assay, 10mg each of the wild-type
and mutant Smyd3 proteins were incubated with 40mg
histone mixture extracted from calf thymus (Sigma)
along with 0.5mCi [methyl-
3H]-S-adenosylmethionine
(PerkinElmer Life Sciences) as the methyl donor for 2h
at 30 C, in a total volume of 40ml with a buffer containing
50mM Tris–HCl, 100mM NaCl and 1mM DTT. The
HKMT activity was analyzed by liquid scintillation
counting. As a negative control, the background reading
was measured from the assay system containing the
wild-type Smyd3 and the labeled cofactor but no histone
mixture, which was subtracted from the readings of the
other assay experiments. For some Smyd3 mutants, the
experimental readings were slightly lower than the back-
ground reading, resulting in the apparent ‘negative
activities’ after subtraction of the background reading.
This also indicates that these mutants had no detectable
enzymatic activity towards H3K4. The HKMT activity of
Smyd3 increases substantially with the increase in pH
Table 1. Summary of diffraction data and structure reﬁnement statistics
Form I Form II Form III
Diffraction data
Wavelength (A ˚ ) 0.99985 0.97908 0.97908
Space group P21 P212121 P61
Cell parameters
a, b, c (A ˚ ) 58.0, 118.0, 82.8 55.0, 101.0, 117.3 103.4, 103.4, 112.2
a, b, g ( ) 90.0, 91.8, 90.0 90, 90, 90 90, 90, 120
Resolution (A ˚ ) 50.0–2.8 (2.90–2.80)
a 50–3.6 (3.73–3.60)
a 50–3.4 (3.52–3.40)
a
Observed reﬂections 86956 29147 69514
Unique reﬂections (I/ (I) > 0) 26338 6662 9395
Average redundancy 3.3 (3.0) 4.4 (3.0) 7.4 (5.9)
Average I/ (I) 9.8 (2.9) 10.1 (2.1) 16.6 (2.5)
Completeness (%) 97.9 (94.4) 82.8 (68.4) 99.9 (100)
Rmerge (%)
b 12.2 (33.9) 12.6 (33.3) 13.0 (64.9)
Reﬁnement and structure model
Reﬂections (Fo 0 (Fo))
Working set 24970 6299 8866
Test set 1323 340 487
R factor/free R factor (%)
c 21.1/26.1 24.1/28.3 22.4/24.9
Number of non-H atoms 6896 3443 3426
Number of amino acid residues 851 426 424
Number of water molecules 24 – –
Average B factor (A ˚ 2)
All atoms 40.3 103.4 97.4
Protein 40.3 103.4 97.8
Ligand/ion 39.8/39.4 108.1/104.4 54.7/58.6
Water 24.6 – –
RMSD
Bond lengths (A ˚ ) 0.007 0.009 0.008
Bond angles ( ) 1.1 1.2 1.1
Ramachandran plot (%)
Most favoured regions 92.1 83.6 86.2
Allowed regions 7.7 15.9 12.5
Generously allowed regions 0.3 0.5 1.3
aNumbers in parentheses represent the highest resolution shell.
bRmerge ¼
P
hkl
P
i jIiðhklÞi  < IðhklÞ > j=
P
hkl
P
i IiðhklÞ:
cR ¼
P
hkl jjFoj j Fcjj=
P
hkl jFoj:
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mutations of residues at the active site, the assays were
performed at pH 8.0. To examine the stimulatory effect
by DNA, the HKMT activities of the wild-type Smyd3
and the R66E mutant were measured at the physiological
pH 7.4 with and without the 6bp potential target DNA
(50-CCCTCC-30).
RESULTS AND DISCUSSION
Overall structure
Crystallization of the full-length human Smyd3 in complex
with the cofactor product AdoHcy was carried out, and
three different forms of crystals belonging to three different
space groups (P21, P212121 and P61) have been obtained
(Table 1). The structures derived from the three forms of
crystals are all similar with AdoHcy and three Zn
2+ ions
bound at similar positions, and the one (form I) reﬁned to
the highest resolution (2.8A ˚ ) was used for further struc-
tural analysis and discussion. As shown in Figure 1A and
B, the Smyd3–AdoHcy complex assumes a compact
globular structure. The N-terminal region including the
SET domain (residues 1–43 and 94–242), the MYND
domain (residues 44–93) and the post-SET domain
(residues 243–270) has a mixed structure consisting of a
helices (a1–a7), b-strands (b1–b12) and long extended
loops, while the C-terminal region (residues 271–428) is
comprised of mainly a helices (a8–a15) (Figure 1A and
Supplementary Figure S2). Our Smyd3–AdoHcy structure
is very similar to the Smyd3 structure in complex with
AdoMet (PDB code 3MEK) which was derived from a
crystal of space group P212121 with an RMSD of 0.9A ˚
for all Ca atoms. In addition, the structures of the active
site are almost identical in the two complexes with AdoHcy
and AdoMet bound in a similar mode.
The overall architecture of the SET domain of Smyd3 is
similar to the other SET domains of HKMTs. The core
region (residues 1–40 and 180–242) of the SET domain is
comprised largely of three canonical b sheets (b1 and b2;
b3, b10 and b11: and b4, b7 and b8) and extended loops.
Structural comparison of the SET domain of Smyd3
(Smyd3-SET) with those of the other SET methyl-
transferases (17–21,23–29,35–37) especially the H3K4-
speciﬁc enzymes SET7/9 (18,21,23,25) and MLL1 (29)
shows that the SET domain of Smyd3 mostly resembles
that of SET7/9 with an RMSD of 2.2A ˚ based on super-
position of the core region of the SET domain (Figure 1B).
In addition, in a surface pocket formed by the SET and
post-SET domains, the cofactor product AdoHcy binds in
the same position and conﬁguration as those in the SET7/
9–AdoHcy complex (Figure 1B), and the overall structure
of the cofactor binding site is generally similar to that of
SET7/9 (see details later). However, unlike SET7/9, the
post-SET domain of Smyd3 is Cysteine-rich and a Zn
2+
ion is bound and coordinated by residue Cys208 of the
SET domain, and residues Cys261, Cys263 and Cys266 of
the post-SET domain (Figure 1C, left panel). Comparison
of Smyd3 with the other methyltransferases containing a
Cysteine-rich post-SET domain such as MLL1 (29), Dim5
(22,38) and Suv39H2 (17) shows that the position and
coordination of the bound Zn
2+ in these enzymes are
similar; however, the overall structures of the post-SET
domains are quite different: the post-SET domain of
Smyd3 is comprised of an N-terminal a helix (a6), a
loop and a C-terminal a helix (a7), whereas that of the
other enzymes mainly forms a long loop (Figure 1C, right
panel). Intriguingly, although the post-SET region
of Smyd3 shares little sequence similarity with that of
SET7/9, the N-terminal part of the post-SET region of
Smyd3 resembles that of SET7/9 by forming an a helix
(a6) (Figure 1C, left panel). These results demonstrate that
Smyd3 has a distinctive Zn
2+-binding post-SET motif.
The characteristic MYND domain forms a relatively
independent structure, comprised of mainly a long
extended loop, a short b sheet (b5 and b6) and two a
helices (a1 and a2) (Figure 1D). The MYND domain is
characterized by a C6HC zinc chelating motif, and as
expected, the MYND domain in our structure is bound
with two Zn
2+ ions (Figure 1D).
Tetratrico-peptide repeat domain
Search with the Dali server (http://ekhidna.biocenter
.helsinki.ﬁ/dali_server) reveals that the C-terminal region
is mainly comprised of a tetratrico-peptide repeat (TPR)
domain (residues 280–428, a9–a15 and Z5) consisting of
three TPR motifs which are degenerate 34 amino acid se-
quences and assume helix-turn-helix structures
(Supplementary Figure S3). TPR repeats have been
found in many proteins to mediate protein–protein and
sometimes, protein–lipid interactions. It has been
reported that Hsp90a binds to Smyd3 to enhance its
methyltransferase activity (6), and intriguingly,
numerous TPR domain-containing proteins, including
Hop, CyP40, FKBP51/52 and p23, have been shown to
bind to Hsp90 (39–42). In the crystal structure of the
C-terminal TPR2 domain of Hop in complex with a
C-terminal pentapeptide (MEEVD) of Hsp90, the
peptide binds to a helical groove and is anchored to the
TPR domain of Hop mainly through interactions of a
highly conserved two-carboxylate clamp of the peptide
with ﬁve residues of TPR2 which are also conserved in
the TPR1 domain of Hop (43). Although the overall con-
ﬁguration of the TPR domain of Smyd3 is similar to
TPR2 of Hop (RMSD of 4.9A ˚ based on 128 Ca atoms),
the C-terminal region of the second TPR motif (a12)
forms a long distorted a helix and hence the a helices at
the C-terminus are almost perpendicular to their corres-
ponding regions in the structure of the Hop–Hsp90
peptide complex. The molecular mechanism underlying
the Smyd3–Hsp90a interaction is under investigation.
Histone binding pocket
Our attempts to obtain a structure of Smyd3 in complex
with the histone peptide were unsuccessful. The Smyd3–
AdoHcy structure was superposed to the structure of
SET7/9 in complex with a methylated histone peptide
(PDB code 1O9S) (25) (Figures 1B and 2A). In SET7/9,
a narrow lysine channel is detected connecting the
cofactor binding site and the histone peptide binding site
(25). In the Smyd3–AdoHcy complex, a similar channel is
Nucleic Acids Research, 2011,Vol.39, No. 10 4441Figure 1. Structure of the Smyd3–AdoHcy complex. (A) Overall structure of the Smyd3–AdoHcy complex. Top: a schematic representation of the
full-length Smyd3 with the N-terminal SET domain (residues 1–43 and 94–242), the MYND domain (residues 44–93), the post-SET domain (residues
243–270), and the C-terminal region (residues 271–428) colored in magenta, yellow, cyan and blue, respectively. Bottom: two views of the overall
structure of the Smyd3–AdoHcy complex. The domains are colored accordingly and the secondary structure elements are marked. The cofactor
product AdoHcy is shown with a ball-and-stick model and colored in cyan. (B) Structural comparison of the SET and post-SET domains of Smyd3
with the equivalent regions of SET7/9 (PDB code 1O9S). Superposition of the Smyd3 and Set7/9 structures was performed based on the core region
of the SET domain. SET7/9 is colored in green, and the color coding for Smyd3 is the same as in Figure 1A. The cofactors are shown with
ball-and-stick models and colored accordingly. (C) Comparison of the Zn
2+-binding site in the catalytic core of Smyd3 with the equivalent regions of
SET7/9 (left panel) and Dim 5 (PDB code 1PEG, right panel). The post-SET regions of Smyd3, SET7/9 and Dim5 are shown with ribbon
representations and colored in cyan, green and wheat, respectively. The side chains of the involved Cys residues and the bound cofactors are
shown with ball-and-stick models and colored accordingly. The Zn
2+ ions are shown with sphere models and colored accordingly. The secondary
structure elements and the involved Cys residues in Smyd3 are labeled. (D) Zinc-binding sites in the MYND domain. The MYND domain (yellow) is
characterized by a C6HC zinc chelating motif. The side chains of the Cys and His residues chelating the two Zn
2+ ions are shown with ball-and-stick
models. The Zn
2+ ions are shown with sphere models. The secondary structure elements and the involved residues are labeled.
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AdoHcy binds at an almost identical position as in the
SET7/9 complex (Figure 1B). Thus, we reason that the
histone substrate of Smyd3 should bind at the other end
of the channel as observed in SET7/9. In the SET7/9 struc-
tures, the histone peptide binding site is quite open as the
N-terminal pre-SET domain is distant from the active site
(21,25). In the Smyd3 structure, however, the TPR
domain encloses a large part of the substrate binding
site, and together with the SET and post-SET domains
forms a deep and narrow substrate binding pocket
(Figure 2A and B). Detailed examination of the pocket
shows that several acidic residues, including Glu192 and
Asp241 of the SET domain and Asp332 of the TPR
domain are located at the opening of the substrate
binding pocket, and might be involved in histone
binding (Figure 2B).
The mutagenesis analyses clearly show that truncation
of the TPR domain (277–428) resulted in an approxi-
mately 4-fold decrease in the HKMT activity, indicating
an important, but not critical, role of the TPR domain
(Figure 2C). Furthermore, mutation of either Asp241 or
Asp332 to Ala indeed had a negative impact with 60–75%
reduction of the HKMT activity of Smyd3, and intri-
guingly, double mutation of Asp241 and Asp332 almost
completely abrogated the enzymatic activity (Figure 2C).
Mutation of Glu192 to Ala had a minor effect, implying
that Glu192 might not be directly involved in histone
binding (Figure 2C). Taken together, the structural and
biochemical data demonstrate that the TPR domain and
the acidic property of the opening of the substrate binding
pocket are important for the HKMT activity of Smyd3. In
particular, residues Asp241 of the SET domain and
Asp332 of the TPR domain play key roles in the
HKMT reaction, most likely through the binding of the
histone substrate.
Cofactor binding pocket
AttheactivesiteoftheSmyd3–AdoHcystructure,AdoHcy
is bound in a pocket surrounded by the b1–b2 loop, the
Z1–Z2 loop and b9 of the SET domain and the a6–a7 loop
of the post-SET domain (Figure 1B) with well-deﬁned
electron density (Figure 3A). Similar to AdoHcy bound
in the SET7/9 structures (18,25), the cofactor takes a
Figure 2. Histone binding pocket. (A) Potential histone peptide binding site. Superposition of the Smyd3 and SET7/9 (PDB code 1O9S) structures
was performed as in Figure 1B. Smyd3 is shown in a ribbon representation with the same color coding as in Figure 1A. For simplicity, for SET7/9
only the bound histone peptide is shown in a ribbon representation and colored in green and the side chain of the methyllysine of the histone peptide
is shown with a ball-and-stick model and colored accordingly. The cofactor is also shown with a ball-and-stick model. (B) Electrostatic potential
surface of the potential histone peptide binding pocket in Smyd3. The surface charge distribution is displayed as blue for positive, red for negative,
and white for neutral. A close-up view of the pocket (middle panel) shows that several acidic patches are present at the opening of the binding
pocket. Some of the acidic residues in these patches are labeled. The TPR domain forms part of the substrate binding pocket and removal of the
TPR domain would leave an incomplete pocket (right panel). (C) HKMT activity assays of the wild-type Smyd3 and the mutants with truncation or
mutations at the substrate binding pocket. The activities of the truncate with deletion of the C-terminal region (277–428) and the mutants carrying
one or two point mutations of the residues potentially involved in histone binding were determined. Activity is shown as the relative activity of the
proteins normalized to that of the wild-type protein. The experiments were performed in triplicates and the error bars indicate the standard deviation.
Nucleic Acids Research, 2011,Vol.39, No. 10 4443U-shape conformation in the Smyd3 structure (Figure 3B).
The adenine ring of AdoHcy makes a p–p stacking inter-
action with the side chain of Phe259, and the N6 atom of
the adenine forms a hydrogen bond with the main-chain
carbonyl of His206. For stabilization of the ribose ring, the
O20 atomformsahydrogenbondwiththeside-chainamino
group of Asn132, and the O30 atom forms hydrogen bonds
with the side-chain carbonyl of Asn132 and the main-chain
carbonyl of Tyr257. The amide group of the homocysteine
is hydrogen-bonded to the main-chain carbonyl groups of
Arg14 and Asn16 and the side-chain carbonyl of Asn205.
The carboxyl group forms hydrogen bonds with the main-
chainamideofAsn16andthephenolichydroxylofTyr124.
Besides the residues that interact directly with AdoHcy,
residue Asp262 of the post-SET domain might contribute
to the cofactor binding as it forms a salt bridge with Arg14
to stabilize the positions of Arg14 and the b1–b2 loop
where Arg14 is located, and perhaps interacts with the
N1 and N6 atoms of the adenine moiety via a water
molecule not seen at this resolution of diffraction data
(Figure 3B). In addition, similar to its equivalent
(Tyr335) in SET7/9 (25), Tyr239 may also make van der
Waals interactions with the O40 atom of the ribose ring
(Figure 4A).
Although in Smyd3 the cofactor binds at an equivalent
position and assumes a similar conformation as in SET7/9
(18,25), there are notable differences in the cofactor
binding mode between Smyd3 and SET7/9. As shown in
Figure 3B, in the SET7/9–AdoHcy structure, the adenine
ring of AdoHcy makes a p–p stacking interaction with
Trp352, and the N1 atom forms a hydrogen bond with
Glu356 of the post-SET domain. The carboxylate of the
homocysteine moiety is not stabilized by the equivalent
residue of Tyr124, instead by the main-chain carbonyl
and amide of Glu228. In addition, the ribose moiety of
SET7/9 does not make interactions with the surrounding
residues.
Validation of the functional roles of these residues with
mutagenesis analyses has not been performed previously
except for the equivalents of Asn205 (21) and Tyr239 (20–
22,27). Since Tyr239 has other important functions
besides the cofactor binding, the results of the mutagenesis
analyses of Tyr239 will be discussed later. As shown in
Figure 3C, mutations of Tyr124, Asn132, Phe259 and
Asp262 to Ala substantially impaired the HKMT
activity of Smyd3, indicating the importance of their func-
tional roles. In particular, mutation of Phe259 which inter-
acts with the adenine ring and mutation of Asn132 which
is hydrogen-bonded to both O20 and O30 of the ribose
almost completely abolished the enzymatic activity of
Smyd3. Since Phe259 belongs to the post-SET domain,
the results are consistent with a critical role of the
post-SET domain in the cofactor binding and the
HKMT activity of Smyd3.
Lysine channel and implications on the catalytic
mechanism
In the SET7/9 structure, a lysine channel connecting the
histone peptide binding site and the cofactor binding site is
found to accommodate the side chain of the methylated
Figure 3. Cofactor binding pocket. (A) A representative simulated-annealing omit Fo–Fc electron density map (contoured at 2.0 s level) for the
cofactor product AdoHcy. (B) A detailed comparison of the cofactor binding mode of Smyd3 (left panel) with that of SET7/9 (right panel, PDB code
1O9S). The hydrogen bonds are indicated with black dotted lines. The residues contributing to the cofactor binding with their side chains are labeled
in orange, and those with their backbones in black. Depending on the contributing moieties, the side chains or backbones of the residues involved in
the AdoHcy binding are shown with ball-and-stick models. The color coding is the same as in Figure 1A. (C) HKMT activity assays of the wild-type
Smyd3 and the mutants carrying point mutations at the cofactor binding pocket.
4444 Nucleic Acids Research, 2011,Vol.39, No. 10H3K4 (25). In the Smyd3 structure, a narrow channel is
also found at a similar site and thus is a potential binding
site of the side chain of H3K4 (Figure 4A). However, a
detailed comparison of the two enzymes reveals signiﬁcant
differences at this site: the lysine channel of SET7/9 is
formed mainly by residues Leu267, Tyr245, Tyr305,
Tyr335 and Tyr337, while the lysine channel of Smyd3
contains only two Tyr residues (Tyr257 and Tyr239)
(Figure 4A). In Smyd3, the positions where Leu267 and
Tyr305 of SET7/9 are located are occupied by Phe183 and
Ile214, respectively, and those where the phenol rings of
Tyr337 and Tyr245 reside are vacant. In addition,
although the position of the hydroxyl of Tyr337 is
occupied by the hydroxyl of Tyr257, the side chain of
Tyr257 approaches this site from an opposite side and
correspondingly the hydroxyl group points to a different
direction. Surprisingly, further comparison of the struc-
ture of the active site of Smyd3 with those of other
lysine methyltransferases shows that the lysine channel
of Smyd3 most resembles that of a non-HKMT, namely
pea Rubisco large subunit methyltransferase (LSMT) (20)
which, like Smyd3, is able to catalyze tri-methylation of
lysine (Figure 4B). The base of the lysine channel should
be the binding site for the methyl groups of the lysine
substrate. In Smyd3, the base of the lysine channel
which is surrounded by Phe183, Asn181 and Tyr239 is
slightly larger than that in Rubisco LSMT. Further exam-
ination and comparison of the Smyd3 structure with that
of the Y245A mutant of SE7/9 in complex with a
tri-methylated peptide of TAF10 (PDB code 3M5A)
clearly show that the base of the lysine channel in
Smyd3 is sufﬁcient to accommodate three methyl groups
(Supplementary Figure S4), which is required by its
activity to tri-methylate the substrate.
In all of the three structures, the Tyr residues (Tyr239 of
Smyd3, Tyr335 of SET7/9 and Tyr287 of Rubisco LSMT)
which correspond to the absolutely conserved Tyr residue
in all of the identiﬁed SET enzymes, adopt similar pos-
itions and conﬁgurations (Figure 4A and B). During the
methyl transfer reaction, the methyl acceptor Lys needs to
be deprotonated, and it has been proposed that Tyr
residues at the active site of methyltransferases are respon-
sible for deprotonating the Ne group of the Lys substrate
(18,20,22,23,25). Speciﬁcally, Trievel et al. originally
proposed that in pea Rubisco LSMT, the methyl
transfer is catalyzed by Tyr287 (20). However, later this
notion was put in doubt by the same group as in their
ternary structure of Rubisco LSMT in complex with a
free e-N-methyllysine and AdoHcy, the Ne group of Lys
forms a hydrogen bond with the main-chain carbonyl of
Arg222 and is more than 3.3A ˚ away from the Tyr287
hydroxyl (44). In addition, a study of a viral histone
H3K27 methyltransferase argued that the corresponding
Tyr of this enzyme is unlikely to act as a general base as
the Tyr to Phe mutant exhibited little activity at pH 8.0 or
above pH 9.0 (27). However, recently a deprotonation role
of SET7/9-Tyr335 is again supported by simulation
studies of SET7/9 which indicate that prior to the
binding of the cofactor, Tyr335 can be deprotonated by
bulk water molecules and then acts as a general base to
deprotonate the Lys amine group (45). Thus, the mechan-
ism to achieve deprotonation of the Ne group of the Lys
substrate is still inconclusive and deserves more
investigation.
Although the active site of Smyd3 is similar to that of
Rubisco LSMT, there are notable differences (Figure 4B).
In particular, Asn181 of Smyd3, equivalent to Arg222 of
Rubisco LSMT, is unlikely to interact with the Lys sub-
strate as the main-chain carbonyl of Asn181 points away
from the lysine channel and this conformation of Asn181
Figure 4. Structure of the lysine channel. (A) Comparison of the lysine
channels of Smyd3 and SET7/9 (PDB code 1O9S). Superposition of the
active sites of Smyd3 and SET7/9 reveals a narrow channel in Smyd3
which is similar to the lysine channel of SET7/9. The key residues
forming the lysine channel are shown with ball-and-stick models. The
color coding is the same as in Figure 1A. (B) Superposition of the
active sites of Smyd3 and pea Rubisco LSMT (PDB code 1P0Y).
The residues are shown with ball-and-stick models, and for clarity,
the side chains of Asn181 of Smyd3 and Arg222 of Rubisco LSMT
are hidden. The color coding for Smyd3 is the same as in Figure 1A,
and Rubisco LSMT is colored in light gray. (C) HKMT activity of the
wild-type Smyd3 and the mutants carrying point mutations at the lysine
channel.
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effect of mutations of the residues involved in the forma-
tion of the lysine channel on the HKMT activity of
Smyd3, including Phe183, the only two Tyr residues
(Tyr239 and Tyr257), and Ser202. Mutation of Phe183
to Ala completely abrogated the HKMT activity of
Smyd3, exhibiting a critical role of Phe183 in the mainten-
ance of the integrity of the lysine channel and in the inter-
action of Smyd3 with the Lys substrate (Figure 4C). The
S202A and Y257F mutants retain more than half of the
HKMT activity, indicating that they play less important
roles in the catalysis (Figure 4C). In contrast, mutation of
Tyr239 to Phe or Ala completely abolished the enzymatic
activity, demonstrating a key role of this residue in the
HKMT reaction (Figure 4C).
Mutation of Tyr239 may affect the HKMT activity of
Smyd3 in three ways: change of the cofactor binding
afﬁnity, disruption of the lower part of the lysine
channel and loss of the ability to accelerate deprotonation
of the Ne group of the Lys substrate. The possibility of the
involvement of Tyr239 in the cofactor binding is inferred
from the observation that its equivalent of SET7/9
(Tyr335) makes van der Waals contacts with the ribose
ring of AdoHcy (18). However, in Smyd3, the effect of
the Tyr239 mutation on the cofactor binding should be
trivial as the ribose ring of AdoHcy is stabilized by three
hydrogen bonds with Asn132 and Tyr257 (Figure 3B) and
the potential interactions of Tyr239 with the cofactor
might be expected to contribute little to the cofactor
binding. It is also noteworthy that the hydroxyl group
of Tyr239 forms a hydrogen bond with the main-chain
carbonyl of Leu204 of the Z4-b9 loop which might stabil-
ize the position of the side chain of Tyr239, and hence
mutation of Tyr239 to Ala or Phe might lead to disruption
of the lysine channel due to the loss of the large side chain
in the Y239A mutant or the instability of the phenol ring
in the Y239F mutant. Therefore, we further mutated
Tyr239 to Lys or a neutral residue Gln both of which
might retain the interaction with the carbonyl of Leu204
but are unable to deprotonate a Lys amine. Again, both
the Y239K and Y239Q mutations led to complete loss of
the enzymatic activity of Smyd3 (Figure 4C). However,
the intactness of the lysine channel in these mutants
needs further investigation. Taken together, the structural
analyses and biochemical assays indicate that the hydroxyl
group of Tyr239 is critical for the HKMT activity of
Smyd3.
Modulation of the HKMT activity via DNA binding of
the MYND domain
The MYND domain was originally named due to its
presence in ETO (also named myeloid tumor gene 8)
and Drosophila proteins Nervy and Deaf1 (46), and later
has been found in numerous other proteins including the
Smyd proteins (47), BS69 (48), mammalian programmed
cell death proteins 2 (49), and AML1/ETO which is a
fused protein resulted from the t(8;21) translocation in
acute myeloid leukemia. Comparison of the structure of
the MYND domain of Smyd3 with other reported
MYND structures shows that it most resembles the
MYND domain of AML1/ETO (50) with an RMSD of
0.57A ˚ . Despite a very similar overall structure, there are
differences in certain regions. For example, a loop encom-
passing residues 55–59 in Smyd3 takes a conformation
different from that of the equivalent loop in AML1/
ETO. In addition, residues 86–93 of Smyd3 form helix
a2 while the equivalent residues form a loop in AML1/
ETO.
It has been indicated that the MYND domain of
AML1/ETO binds the PPPL1 motif of retinoid and
thyroid hormone receptor SMRT corepressor (50). In
the structure of the MYND domain of AML1/ETO
which is fused to the PPPL1 motif of SMRT, the conform-
ation of the MYND domain is similar to that of the
unbound form, and the three residues Ser675, Gln688
and Trp692 of the MYND domain located in a hydropho-
bic pocket interact with the PPPLI motif of the SMRT
peptide (50). In the MYND domain of Smyd3, the equiva-
lent residues (Ser63, Glu76 and Trp80, respectively) are
conserved. However, the electrostatic properties of the
residues surrounding the hydrophobic pocket exhibit sub-
stantial differences, with the replacement of acidic residues
(Glu672 and Glu692) of AML1/ETO with hydrophobic
residues (Met60 and Pro81) and substitution of residues
Thr673 and His689 with highly basic residues (Arg61 and
Lys77) (Figure 5A). With the presence of additional Lys
and Arg residues, the surface of the MYND domain in
Smyd3 is largely positively charged (Figure 5A), which is
in agreement with its potential role in the binding of
speciﬁc DNA sequences such as 50-CCCTCC-30 and
further in transcriptional regulation of the targets
including Nkx2.8 (6).
To examine the hypothesis that the MYND domain of
Smyd3 may directly bind the DNA element, two Smyd3
mutants were generated: the R66E mutant in which an
acidic residue is placed on the positively charged
MYND surface and a negative control mutant E192A
which has an intact MYND domain. The wild-type and
mutant Smyd3 proteins were incubated with the potential
target of 6-bp duplex DNA with the sequence of 50-CCCT
CC-30. As shown in Figure 5B, the DNA exhibited a
slower migration rate in the presence of the wild-type
Smyd3 or the E192 mutant but not the R66E mutant. It
was reported that pre-incubation of yeast methyl-
transferase Dot1p with DNA could stimulate its HKMT
activity on histones (51); therefore, we further examined
the possibility that the DNA-binding ability of the
MYND domain might affect the HKMT activity of
Smyd3. In the presence of the potential target DNA, the
HKMT activity of the wild-type Smyd3 was indeed
increased in a dose-dependent manner (Figure 5C). The
enhancement of the HKMT activity by DNA, however,
did not occur when Arg66 is mutated to Glu, indicating
that the DNA-binding ability of the MYND domain is
essential for stimulating the enzymatic activity of Smyd3
by DNA. Taken together, our data demonstrate for the
ﬁrst time that the DNA binding of Smyd3 stimulates its
HKMT activity, and the MYND domain may mediate the
process through direct binding with the target DNA.
Intriguingly, comparison of the MYND domains of the
Smyd proteins shows that some of the basic residues of
4446 Nucleic Acids Research, 2011,Vol.39, No. 10Smyd3 (Arg61, Arg66, Lys77 and Lys84) are conserved in
Smyd1 and Smyd2 (Figure 5D), implying that Smyd1 and
Smyd2 may utilize a similar mechanism to regulate their
HKMT activities.
PROTEIN DATA BANK ACCESSION CODES
The structures of Smyd3 in crystal forms I, II and III have
been deposited with the RCSB Protein Data Bank under
accession codes 3OXF, 3OXL and 3OXG, respectively.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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